The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
MEDICAL FRONTIERS - 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Novel Insulin-Independent Mechanism of Action Hits Triple Targets in Type 2 Diabetes
Barcelona, Spain / November 8-11, 2012
Barcelona - Management of type 2 diabetes mellitus (T2DM) implies more than achieving good glycemic control as most patients have comorbid conditions including high blood pressure (BP) and dyslipidemia. Most are overweight or obese as well....
Hemophilia Management: Evaluating RICE and Factor Replacement Therapy with Longer Half-life
Orlando, Florida / November 8-10, 2012
Orlando - Conservative therapy in the management of joint and muscle bleeding in patients with hemophilia has consisted primarily of interventions known collectively as RICE: rest, ice, compression and elevation. A critical assessment of...
Options for Iron Correction and Erythropoiesis Stimulation: Better Benefit:Risk Through Individualized Therapy
San Diego, California / October 30 - November 4, 2012
San Diego - More sophisticated strategies for the treatment of anemia in patients with chronic kidney disease (CKD), including those on dialysis, are being driven by new options for replenishing iron and stimulating erythropoiesis. The...
Halting Threat of Kidney Failure by Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies
San Diego, California / October 30-November 4, 2012
San Diego - Two-year results with a targeted monoclonal antibody (MAb) against the complement protein C5 demonstrated that the kidney damage caused by atypical hemolytic uremic syndrome (aHUS) and shiga-toxin producing Escherichia coli HUS...
Effective Event Reduction in the Era of New Oral Anticoagulants: Pursuing Options
Toronto, Ontario / October 27-31, 2012
Toronto - After 50 years of warfarin use for stroke prevention in atrial fibrillation (AF), there are now 3 new oral anticoagulants equal to, or better than warfarin for stroke prevention. Importantly, they are safer than warfarin in terms...
Optimal Control of Hypertension: From Lifestyle Modifications to Fixed-Dose Combinations
Toronto, Ontario / October 25-28, 2012
Toronto - Over 1000 patients in Canada are diagnosed with hypertension each day. Best treatment plan depends on factors including severity of high blood pressure (BP), age, comorbidities, as well as, patient and physician preference. Common...
A Template for Improved Blood Pressure Control and Better Adherence: Integrating Third Generation b-blockers and Single-pill Multiple Mechanism Combinations
Toronto, Ontario / October 25-28, 2012
Toronto - For the prevention, diagnosis and treatment of high blood pressure (BP), the Canadian Hypertension Education Program (CHEP) guidelines provide a template against which physicians can tailor antihypertensive regimens according to...
MEDICAL FRONTIERS - 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Expansion of MS Therapies: Multicentre Phase III Trials of First-Line Oral Agents
Lyon, France / October 10-13, 2012
Lyon - Oral therapies for the control of multiple sclerosis (MS) are poised to proliferate, based on data presented at the 2012 ECTRIMS. Phase III trials have associated several agents with high rates of efficacy both in regard to the risk...
MEDICAL FRONTIERS - 15th Annual Canadian Diabetes Association (CDA)/ Canadian Society of Endocrinology & Metabolism (CSEM) Professional Conference and Annual Meeting
Inhibiting Kidney Glucose Reabsorption: A Novel Insulin-independent Therapy in Type 2 Diabetes Mellitus
Vancouver, BC / October 10-13, 2012
Vancouver - New updated guidelines on the management of type 2 diabetes mellitus are expected early in 2013. A preview of the new guidelines indicates that glycemic targets may be relaxed in select patients and that the individualized...